@misc{10481/72588,
year = {2021},
month = {12},
url = {http://hdl.handle.net/10481/72588},
abstract = {Background: Gestational diabetes (GDM) impacts 8–18% of pregnancies and greatly increases both maternal and
child risk of developing non-communicable diseases such as type 2 diabetes and obesity. Whilst lifestyle
interventions in pregnancy and postpartum reduce this risk, a research translation gap remains around delivering
implementable interventions with adequate population penetration and participation. Impact Diabetes Bump2Baby
is an implementation project of an evidence-based system of care for the prevention of overweight and obesity.
Bump2Baby and Me is the multicentre randomised controlled trial investigating the effectiveness of a mHealth
coaching programme in pregnancy and postpartum for women at high risk of developing GDM.
Methods: Eight hundred women will be recruited in early pregnancy from 4 clinical sites within Ireland, the UK,
Spain, and Australia. Women will be screened for eligibility using the validated Monash GDM screening tool.
Participants will be enrolled from 12 to 24 weeks’ gestation and randomised on a 1:1 basis into the intervention or
control arm. Alongside usual care, the intervention involves mHealth coaching via a smartphone application, which
uses a combination of synchronous and asynchronous video and text messaging, and allows for personalised
support and goal setting with a trained health coach. The control arm receives usual care. All women and their
children will be followed from early pregnancy until 12 months postpartum. The primary outcome will be a
difference in maternal body mass index (BMI) of 0.8 kg/m2 at 12 months postpartum. Secondary maternal and infant
outcomes include the development of GDM, gestational weight gain, pregnancy outcomes, improvements in diet,
physical activity, sleep, and neonatal weight and infant growth patterns. The 5-year project is funded by the EU Commission Horizon 2020 and the Australian National Health and Medical Research Council. Ethical approval has
been received.
Discussion: Previous interventions have not moved beyond tightly controlled efficacy trials into routine service
delivery. This project aims to provide evidence-based, sustainable support that could be incorporated into usual
care for women during pregnancy and postpartum. This study will contribute evidence to inform the early
prevention of non-communicable diseases like obesity and diabetes in mothers and the next generation.},
organization = {European Union Commission Horizon 2020 grant entitled 'Implementation Action to Prevent Diabetes From Bump 2 Baby (IMPACT DIABETES B2B)'	847984},
organization = {National Health and Medical Research Council of Australia	APP1194234},
organization = {University College Dublin},
organization = {European Commission},
publisher = {BMC},
keywords = {Pregnancy},
keywords = {Gestational diabetes},
keywords = {Obesity},
keywords = {mHealth},
keywords = {Implementation},
keywords = {Postpartum},
keywords = {Health coaching},
keywords = {Maternal health},
keywords = {Weight management},
keywords = {Foetal programming},
title = {Bump2Baby and Me: protocol for a randomised trial of mHealth coaching for healthy gestational weight gain and improved postnatal outcomes in high-risk women and their children},
doi = {10.1186/s13063-021-05892-4},
author = {O'Reilly, Sharleen L. and Campoy Folgoso, Cristina and IMPACT DIABETES B2B Collaboration Group},
}